Mucoral mast cells (MMC) are found mainly wilhin Ihe jejunal submuasa MMC increase in inleslinal graft.versur-host reaction. and their degranulation is observed In paraslltc enleropalhy. Weanlng Is asroclaled wlth morpho9lcal changes resembling those seen in mild cell,mediated inleslinal injury. W e studied MMC in lhe young rat jejunum In relation lo weaning changes. Jejunal morphology. aypl cell production rate, inlraepilhelial lymphocylec (IEL) and goblet cells woro ctudied.
and toluidine blue stained sedions. Serum R M C P I1 was delermined with a direct ELlSA method. In Ihe nexl few days follawlng weaning Ihe jejunal villi shorlened by about 30%. crypts elongated by the same amount. aypl cell produc lion rale more than doubled. and the numbers of IEL showed a marked increase. The M M C aunls showed a steady Increase from birth lo the lime of weaning. sharp fall on the two days immediately after weaning. and further increase thereafler. Serum R M C P I1 level displayed a sudden rise at the lime of weaning. wilh eradual decline thereafler. Muasal masl cell deeranulalion. obviously associaled wilh the event of weaning, may be responsible for the observed morphological changes through epilhelial cell damage. Weanlng Is a period of lemporary loss of oral lolerance In rals: this mlghl be a resull of (elunal Inlury caused by muasal masl cell protease.
IN MICE, GLUTEN IN HATERNAL DIET PRIMES SYSTEMIC IMMUNE RESWNSES
8 m GLImIN IN OFFSPRING R.Troncone, A.Ferpuson Gastro-Intestinal Unit, University of Edinburgh and Western General Hospital, Edinburgh, Scotland, UK Mice reared on a gluten-containing diet (GCD) are immunologically tolerant to gliadln (1). Aim of this study was to investigate whether oral tolerance is recreated in each generation by the ingestion of dietary gluten at weaning, or whether it is transferred from mother to young (as immune status or via passage of antigen) before birth or during lactation. BALB/c mice were used, reared on a gluten-free diet (GTD), born to mothers either from a GFD or a GCD colony. After parenteral immunisation with gliadin, both humoral and cell-mediated immunity were assessed by serun antibody (ELISA) and footpad swelling test, respectively. Unexpectedly, mice born to mothers from a 020 colony showed systemic immune responses to gliadin significantly higher ip(0.05) than mice born to mothers from a GFD colony. Furthermore, feeding mothers GCO for defined periods before and during pregnancy and during lactation, also resulted in priming of the specific immune responses of the offspring. These findings indicate that, in mice, sensitisation to maternal dietary antigens occurs in utero or shortly after birth. This animal model should allow investigation of the immunological mechanisms concerned. Gastm-Intestinal Unlt, University of Edinburgh and Western General Hospital, Edinburgh, Scotland, UK After an experimental stage on piglets small intestine transplantation(SIT)using Cyclosporine A(CsA)we now report a human case.A Hucosal cMI to sliadin is likely to be implicated in the Pathogenesis of coeliac yrs old girl,on home nutrition for short small bowel disease. Our a h ms to induce mucosal CHI to gliadin by feeding gluten-containing (volvulus)for 6 yrs was transplanted with 120cm small intestine diet (GCD) to mice PreViOuSlY Parenterally immunised with this antigen. harvested by an isoblood group A 17 yrs old boy pronouced brain BALB/c mice from a gluten-free diet (GTDI colony were used. They were given parendead.Cross match reaction donor and recipient was negative.After terally gliadln in complete ~reund's adjuvant, and 3 weeks later they were challenand vena cava ischemic time was ged wlth GCD for 7 days. In further experiments the effect of concurrent G W reac3h55mn;both graft and own intestine were exteriorized as stomas.
Immunosuppression included solumedrol 2mg/kg/d and CsA as a contition Was evaluated in BDQl mice on a ED, previously immunised with gliadln. CMI nuous infusion to maintain serum levels between 200-300un,l.Acute responses in small intestinal mucosa were measured by morphometry (villous and graft rejection(GR)occured on day 13 marked only with -an' increased ileostomy drainage;histologic pattern included progressively=villi oedema,Tcell infiltrates(~~4*/~~8+).increased HLAOR expression by enterocyte6,severe crypt damage and ultimately mucosal sloughing.GR was treated with antilymphocyte globulin.No GVH reaction has been observed.The course after CR was marked with a persistant protein losing enteropathy up to a progressive intestine recovery as shown by repeated histologic findings,baryum transit(day 30 and 80)and start oral feeding from day 60.Unfortunately from the 6'month the addition of prolonged CsA IV administration,long term PN and probable viral infection induced severe liver disease and hematologic disorders requiring graft removal after 61 months.The patient died.This course demonstrate that 6 months survival is possible after SIT.Smal1 bowel recovery can be achieved despite extensive mucosal destruction caused be acute graft rejection. IgA class ARA and EMA are both suggested to be good indicators of villous atrophy in coeliac disease (CD). We have now done the tests parallelly in children with untreated CD (521, on gluten-free diet (20) and during gluten challenge (10). Children (50) biopsied because of suspected C D and uith normal mucosa served as controls. Furthermore 100 adult blood donors were tested. Children uith untreated C D uere both ARA and EMA positive (titres 1:10 to 1:BOOO for both). 5 children with IgA deficiency and flat intestinal nucosa uere negative for both tests. During gluten-free diet disappearance of both ARA and EMA correlated well with mucosal recovery. 4 children with normal mucosa were found to have these antibodies in titres 1:5 to 1:200. They all were brothers and sisters to CD patients. All the others uere ARA and EMA negative. One of the blood donors was positive for both tests. On biopsy, subtotal villous atrophy was found. The absorption of antibodies from patient sera uith animal and human tissues and retesting results suggest the antigens for ARA and EMA not to be fully identical. However, in clinical practise no difference betueen ARA and EMA could be seen.
COMPARISON OF RETICULIN (ARA) AND ENDOMYSIUM

7
crypt length, crypt cell production rate ICCPR), and lntraepithelial lymphocytes IIEL) count). Feeding GCD for a week to mice reared on GTD did not produce any change. Similarly, mice given GCD after having been parenterally innunised with gliadln did not show muCOSal CMI. Mice on GCD given both gliadin immunisation and G W showed a significant increase (~(0.05) in crypt depth, CCPR and IEL count, in comparison to ccrLrols given only GVH. These results indicate that systemic immunity to gliadin is not sufficient to induce specific intestinal CHI. Additional factors (enhanced antigen presentation, increased intestinal permeability) are also necessary.
AN HLA-DQ ALPHA ALLELE IDENTIFIED AT DNA AND Giphart .
Depts. of Imnunohaematology and Blood Bank and *Gastroenterology, University Hospital, Leiden. The Netherlands.
Susceptibility genes for coeliac disease are associated with certain HLA-DR genotypes. More recent studies also show strong association with some HLA-DQ alleles. We have examined the presence of disease associated HLA-DQ alleles by restriction fragment length polymorphism (RFPL) with the help of a HLA-DQ alpha cDNA probe. This probe showed upon hybridization a highly significant discrepancy between the RFLP of coeliac disease patients and healthy controls. The 4.0 kb. Bgl I1 restriction fragment was present in 97% of coeliac disease patients (n-30). compared to 56% in a healthy control population (11-72) (RR-14.9; p<0.0005). This fragment is associated with HLA-DR3, -5 , some DRw8, and DRw14Du16. This was confirmed by the analysis of the panel of 72 homozygous typing cells obtained from the Xth International Workshop on Histocompatibility Testing. At the product level all coeliac diseaae patients tested sofar have one D Q alpha chain in common, designated HLA-DQ alpha 2.3, which is associated with the 4.0 kb Bgl I 1 fragment. This HLA-DQ alpha allele identified at the DNA level and product level seems to be a better marker for genetic susceptibility to develop coeliac disease than those available sofar.
